• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年美国儿童、青少年和成年人中超重和肥胖的国家级和州级患病率,以及到2050年的预测。

National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.

出版信息

Lancet. 2024 Dec 7;404(10469):2278-2298. doi: 10.1016/S0140-6736(24)01548-4. Epub 2024 Nov 14.

DOI:10.1016/S0140-6736(24)01548-4
PMID:39551059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694015/
Abstract

BACKGROUND

Over the past several decades, the overweight and obesity epidemic in the USA has resulted in a significant health and economic burden. Understanding current trends and future trajectories at both national and state levels is crucial for assessing the success of existing interventions and informing future health policy changes. We estimated the prevalence of overweight and obesity from 1990 to 2021 with forecasts to 2050 for children and adolescents (aged 5-24 years) and adults (aged ≥25 years) at the national level. Additionally, we derived state-specific estimates and projections for older adolescents (aged 15-24 years) and adults for all 50 states and Washington, DC.

METHODS

In this analysis, self-reported and measured anthropometric data were extracted from 134 unique sources, which included all major national surveillance survey data. Adjustments were made to correct for self-reporting bias. For individuals older than 18 years, overweight was defined as having a BMI of 25 kg/m to less than 30 kg/m and obesity was defined as a BMI of 30 kg/m or higher, and for individuals younger than 18 years definitions were based on International Obesity Task Force criteria. Historical trends of overweight and obesity prevalence from 1990 to 2021 were estimated using spatiotemporal Gaussian process regression models. A generalised ensemble modelling approach was then used to derive projected estimates up to 2050, assuming continuation of past trends and patterns. All estimates were calculated by age and sex at the national level, with estimates for older adolescents (aged 15-24 years) and adults aged (≥25 years) also calculated for 50 states and Washington, DC. 95% uncertainty intervals (UIs) were derived from the 2·5th and 97·5th percentiles of the posterior distributions of the respective estimates.

FINDINGS

In 2021, an estimated 15·1 million (95% UI 13·5-16·8) children and young adolescents (aged 5-14 years), 21·4 million (20·2-22·6) older adolescents (aged 15-24 years), and 172 million (169-174) adults (aged ≥25 years) had overweight or obesity in the USA. Texas had the highest age-standardised prevalence of overweight or obesity for male adolescents (aged 15-24 years), at 52·4% (47·4-57·6), whereas Mississippi had the highest for female adolescents (aged 15-24 years), at 63·0% (57·0-68·5). Among adults, the prevalence of overweight or obesity was highest in North Dakota for males, estimated at 80·6% (78·5-82·6), and in Mississippi for females at 79·9% (77·8-81·8). The prevalence of obesity has outpaced the increase in overweight over time, especially among adolescents. Between 1990 and 2021, the percentage change in the age-standardised prevalence of obesity increased by 158·4% (123·9-197·4) among male adolescents and 185·9% (139·4-237·1) among female adolescents (15-24 years). For adults, the percentage change in prevalence of obesity was 123·6% (112·4-136·4) in males and 99·9% (88·8-111·1) in females. Forecast results suggest that if past trends and patterns continue, an additional 3·33 million children and young adolescents (aged 5-14 years), 3·41 million older adolescents (aged 15-24 years), and 41·4 million adults (aged ≥25 years) will have overweight or obesity by 2050. By 2050, the total number of children and adolescents with overweight and obesity will reach 43·1 million (37·2-47·4) and the total number of adults with overweight and obesity will reach 213 million (202-221). In 2050, in most states, a projected one in three adolescents (aged 15-24 years) and two in three adults (≥25 years) will have obesity. Although southern states, such as Oklahoma, Mississippi, Alabama, Arkansas, West Virginia, and Kentucky, are forecast to continue to have a high prevalence of obesity, the highest percentage changes from 2021 are projected in states such as Utah for adolescents and Colorado for adults.

INTERPRETATION

Existing policies have failed to address overweight and obesity. Without major reform, the forecasted trends will be devastating at the individual and population level, and the associated disease burden and economic costs will continue to escalate. Stronger governance is needed to support and implement a multifaceted whole-system approach to disrupt the structural drivers of overweight and obesity at both national and local levels. Although clinical innovations should be leveraged to treat and manage existing obesity equitably, population-level prevention remains central to any intervention strategies, particularly for children and adolescents.

FUNDING

Bill & Melinda Gates Foundation.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/b97d970e1cb8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/e9288f09bc2a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/8c67415a7873/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/76644f8bcdf1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/6aba07b108d9/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/b97d970e1cb8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/e9288f09bc2a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/8c67415a7873/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/76644f8bcdf1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/6aba07b108d9/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/badb/11694015/b97d970e1cb8/gr5.jpg
摘要

背景

在过去几十年中,美国的超重和肥胖流行给健康和经济带来了巨大负担。了解国家和州层面的当前趋势及未来轨迹对于评估现有干预措施的成效以及为未来的卫生政策变革提供依据至关重要。我们估计了1990年至2021年美国儿童和青少年(5 - 24岁)及成年人(≥25岁)超重和肥胖的患病率,并预测了到2050年的情况。此外,我们还得出了50个州和华盛顿特区15 - 24岁青少年及成年人的州级特定估计值和预测值。

方法

在本分析中,从134个独特来源提取了自我报告和测量的人体测量数据,其中包括所有主要的国家监测调查数据。进行了调整以校正自我报告偏差。对于18岁以上的个体,超重定义为体重指数(BMI)为25 kg/m²至小于30 kg/m²,肥胖定义为BMI为30 kg/m²或更高;对于18岁以下的个体,定义基于国际肥胖特别工作组的标准。使用时空高斯过程回归模型估计了1990年至2021年超重和肥胖患病率的历史趋势。然后采用广义集合建模方法得出到2050年的预测估计值,假设过去的趋势和模式持续。所有估计值均按国家层面的年龄和性别计算,同时也计算了50个州和华盛顿特区15 - 24岁青少年及≥25岁成年人的估计值。95%的不确定性区间(UI)来自各自估计值后验分布的第2.5和第97.5百分位数。

结果

2021年,美国估计有1510万(95% UI 1350 - 1680万)儿童和青少年(5 - 14岁)、2140万(2020 - 2260万)青少年(15 - 24岁)以及1.72亿(1.69 - 1.74亿)成年人(≥25岁)超重或肥胖。德克萨斯州15 - 24岁男性青少年超重或肥胖的年龄标准化患病率最高,为52.4%(47.4 - 57.6%),而密西西比州15 - 24岁女性青少年的患病率最高,为63.0%(57.0 - 68.5%)。在成年人中,北达科他州男性超重或肥胖的患病率最高,估计为80.6%(78.5 - 82.6%),密西西比州女性的患病率为79.9%(77.8 - 81.8%)。随着时间推移,肥胖患病率的增长超过了超重患病率的增长,尤其是在青少年中。1990年至2021年期间,15 - 24岁男性青少年肥胖年龄标准化患病率的百分比变化增加了158.4%(123.9 - 197.4%),女性青少年增加了185.9%(139.4 - 237.1%)。对于成年人,肥胖患病率的百分比变化男性为123.6%(112.4 - 136.4%),女性为99.9%(88.8 - 111.1%)。预测结果表明,如果过去的趋势和模式持续,到2050年将有额外的333万儿童和青少年(5 - 14岁)、341万青少年(15 - 24岁)以及4140万成年人(≥25岁)超重或肥胖。到2050年,超重和肥胖的儿童及青少年总数将达到4310万(3720 - 4740万),超重和肥胖的成年人总数将达到2.13亿(2.02 - 2.21亿)。2050年,在大多数州,预计三分之一的青少年(15 - 24岁)和三分之二的成年人(≥25岁)将患有肥胖症。尽管预计俄克拉荷马州、密西西比州、阿拉巴马州、阿肯色州、西弗吉尼亚州和肯塔基州等南部州的肥胖患病率仍将居高不下,但预计从2021年起变化百分比最高的州在青少年中是犹他州,在成年人中是科罗拉多州。

解读

现有政策未能解决超重和肥胖问题。若不进行重大改革,预测的趋势将在个体和人群层面造成灾难性后果,相关的疾病负担和经济成本将持续上升。需要更强有力的治理来支持和实施多方面的全系统方法,以在国家和地方层面打破超重和肥胖的结构性驱动因素。虽然应利用临床创新来公平地治疗和管理现有的肥胖症,但人群层面的预防仍是任何干预策略的核心,尤其是对于儿童和青少年。

资金来源

比尔及梅琳达·盖茨基金会

相似文献

1
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.1990年至2021年美国儿童、青少年和成年人中超重和肥胖的国家级和州级患病率,以及到2050年的预测。
Lancet. 2024 Dec 7;404(10469):2278-2298. doi: 10.1016/S0140-6736(24)01548-4. Epub 2024 Nov 14.
2
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家儿童及青少年超重和肥胖患病率及到2050年的预测:全球疾病负担研究2021的一项预测研究
Lancet. 2025 Mar 8;405(10481):785-812. doi: 10.1016/S0140-6736(25)00397-6. Epub 2025 Mar 3.
3
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家成人超重和肥胖患病率及到2050年的预测:全球疾病负担研究2021的一项预测研究
Lancet. 2025 Mar 8;405(10481):813-838. doi: 10.1016/S0140-6736(25)00355-1. Epub 2025 Mar 3.
4
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区的全球生育率,1950-2021 年,预测至 2100 年:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):2057-2099. doi: 10.1016/S0140-6736(24)00550-6. Epub 2024 Mar 20.
5
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990 - 2021年美国各州疾病、伤害及风险因素负担:《2021年全球疾病负担研究》的系统分析
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
6
Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.2022 - 2050年美国各州疾病负担情况:《2021年全球疾病负担研究》的预测分析
Lancet. 2024 Dec 7;404(10469):2341-2370. doi: 10.1016/S0140-6736(24)02246-3.
7
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.1990年至2021年以及到2050年的预测中,204个国家和地区的全球、区域和国家层面的艾滋病毒/艾滋病负担:《2021年全球疾病负担研究》
Lancet HIV. 2024 Dec;11(12):e807-e822. doi: 10.1016/S2352-3018(24)00212-1. Epub 2024 Nov 25.
8
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.全球 1975 年至 2016 年的体重指数、消瘦、超重和肥胖趋势:12890 万儿童、青少年和成年人 2416 项基于人群的测量研究的汇总分析。
Lancet. 2017 Dec 16;390(10113):2627-2642. doi: 10.1016/S0140-6736(17)32129-3. Epub 2017 Oct 10.
9
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
10
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.

引用本文的文献

1
Association of obesity-related anthropometric indicators with chronic constipation and diarrhea among U.S. adults: a cross-sectional study.美国成年人中肥胖相关人体测量指标与慢性便秘和腹泻的关联:一项横断面研究。
Front Nutr. 2025 Aug 18;12:1610214. doi: 10.3389/fnut.2025.1610214. eCollection 2025.
2
Peer Coaching to Support Weight Management in Primary Care: A Cluster Randomized Clinical Trial.同伴辅导以支持初级保健中的体重管理:一项整群随机临床试验。
JAMA Netw Open. 2025 Sep 2;8(9):e2529136. doi: 10.1001/jamanetworkopen.2025.29136.
3
The latent profile structure of negative emotion in female college students and its impact on eating behavior: the mediating role of physical exercise.

本文引用的文献

1
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990 - 2021年美国各州疾病、伤害及风险因素负担:《2021年全球疾病负担研究》的系统分析
Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6.
2
Ten Americas: a systematic analysis of life expectancy disparities in the USA.《美国的十个地区:对美国预期寿命差异的系统分析》
Lancet. 2024 Dec 7;404(10469):2299-2313. doi: 10.1016/S0140-6736(24)01495-8. Epub 2024 Nov 21.
3
GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment.
女大学生负面情绪的潜在剖面结构及其对饮食行为的影响:体育锻炼的中介作用
Front Public Health. 2025 Aug 13;13:1663474. doi: 10.3389/fpubh.2025.1663474. eCollection 2025.
4
Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growth.在肥胖加速乳腺癌生长的小鼠模型中,高脂血症会促进肿瘤生长。
Cancer Metab. 2025 Aug 28;13(1):39. doi: 10.1186/s40170-025-00407-0.
5
Global, regional and national burden of diabetes mellitus type 2 attributable to low physical activity from 1990 to 2021 and projections to 2050: a finding from the global burden of disease study 2021.1990年至2021年以及到2050年的预测中,全球、区域和国家层面归因于低体力活动的2型糖尿病负担:全球疾病负担研究2021的一项发现
Front Clin Diabetes Healthc. 2025 Aug 12;6:1606330. doi: 10.3389/fcdhc.2025.1606330. eCollection 2025.
6
Physical Activity and Metabolic Disorders-What Does Gut Microbiota Have to Do with It?体力活动与代谢紊乱——肠道微生物群与此有何关联?
Curr Issues Mol Biol. 2025 Aug 7;47(8):630. doi: 10.3390/cimb47080630.
7
Global status and trends of proteomics in obesity: a bibliometric analysis and knowledge graph study.肥胖症中蛋白质组学的全球现状与趋势:文献计量分析与知识图谱研究
Trop Med Health. 2025 Aug 26;53(1):117. doi: 10.1186/s41182-025-00785-7.
8
Proportion of Obesity-Related Conditions Attributable to Obesity and Overweight in US Youth.美国青少年中归因于肥胖和超重的与肥胖相关疾病的比例。
JAMA Pediatr. 2025 Aug 25. doi: 10.1001/jamapediatrics.2025.2716.
9
Depression and Anxiety Changes Associated with Matched Increases in Physical Activity in Education-, Self-Regulation-, and Self-Regulation Plus Relaxation-Based Obesity Treatments in Women: A Pilot Study Investigating Implications for Controlling Emotional Eating.女性基于教育、自我调节以及自我调节加放松的肥胖治疗中,与体力活动相应增加相关的抑郁和焦虑变化:一项调查对控制情绪化进食影响的试点研究
Nutrients. 2025 Jul 29;17(15):2475. doi: 10.3390/nu17152475.
10
Research progress of potassium-competitive acid blockers in the treatment of .钾离子竞争性酸阻滞剂在治疗方面的研究进展 。(原文句子不完整,翻译可能不太准确,完整准确的翻译需结合完整原文)
Ann Med. 2025 Dec;57(1):2544886. doi: 10.1080/07853890.2025.2544886. Epub 2025 Aug 12.
胰高血糖素样肽-1(GLP-1)激动剂:美国非糖尿病患者开始接受治疗的人数在四年内增长了700%。
BMJ. 2024 Jul 23;386:q1645. doi: 10.1136/bmj.q1645.
4
Interventions for High BMI in Children and Teenagers.儿童和青少年高体重指数的干预措施。
JAMA. 2024 Jul 16;332(3):262. doi: 10.1001/jama.2024.11756.
5
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
6
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
7
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区的全球生育率,1950-2021 年,预测至 2100 年:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):2057-2099. doi: 10.1016/S0140-6736(24)00550-6. Epub 2024 Mar 20.
8
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
9
What is the pipeline for future medications for obesity?未来治疗肥胖症的药物研发流程是怎样的?
Int J Obes (Lond). 2025 Mar;49(3):433-451. doi: 10.1038/s41366-024-01473-y. Epub 2024 Feb 1.
10
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.在肥胖成年人中继续使用替尔泊肽治疗以维持体重减轻:SURMOUNT-4 随机临床试验。
JAMA. 2024 Jan 2;331(1):38-48. doi: 10.1001/jama.2023.24945.